
Pharmaceutical-grade Gliclazide (CAS 21187-98-4) with min. 99% purity, supplied wholesale by Zyntex. Sulfonylurea API for immediate-release and modified-release oral antidiabetic tablets. CoA and SDS with every lot.
Gliclazide (C15H21N3O3S) is a white to almost white powder that is practically insoluble in water and soluble in dichloromethane. It is described in the European Pharmacopoeia and the British Pharmacopoeia.
Pharmaceutical companies use it to formulate immediate-release and modified-release tablets for type 2 diabetes. It belongs to the sulfonylurea class together with Glimepiride and Glibenclamide, and is often used in treatment regimens alongside Metformin Hydrochloride. Modified-release formulations require tight control of particle size, which can be specified on request.
Zyntex supplies it from qualified API producers, with lot-specific documentation available before ordering. The API is supplied only to companies licensed for pharmaceutical use in their country.
Main application areas:
💊 Immediate-Release Tablets
API for conventional oral antidiabetic tablets.
⏱️ Modified-Release Tablets
API for once-daily modified-release formulations.
🔬 Generic Development
Reference and development material for generic dossiers.
🧪 Analytical Use
Reference material for method development and quality control.
| Parameter | Standard Value |
|---|---|
| Product Name | Gliclazide |
| CAS Number | 21187-98-4 |
| Molecular Formula / Weight | C15H21N3O3S / 323.41 g/mol |
| Purity | Pharmaceutical Grade (Min. 99%) |
| Appearance | White to almost white powder |
| Solubility | Practically insoluble in water |
| Documents | CoA and SDS with every lot |
⚠️ Safety & Handling: Pharmacologically active substance: avoid inhalation of dust and contact with skin and eyes. Handle in well-ventilated areas with gloves, eye protection and dust protection. Store in tightly closed containers in a cool, dry place. Always consult the Safety Data Sheet (SDS) for full classification and handling instructions.
What is the difference between gliclazide and glimepiride?
Both are sulfonylurea APIs used in oral antidiabetic medicines. They are different molecules with different dosages and formulation requirements.
Can you supply gliclazide for modified-release tablets?
Yes. Please share your particle size and pharmacopoeia requirements so we can offer a suitable lot.
How can I get a price and documents?
Prices depend on quantity, packaging and destination. Contact us with your required volume to receive a quotation together with the CoA and SDS.